Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future…
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | International Journal of Infectious Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S120197122030148X |
| _version_ | 1819012149493628928 |
|---|---|
| author | Guillaume Desoubeaux Adrien Lemaignen Stephan Ehrmann |
| author_facet | Guillaume Desoubeaux Adrien Lemaignen Stephan Ehrmann |
| author_sort | Guillaume Desoubeaux |
| collection | DOAJ |
| first_indexed | 2024-12-21T01:39:28Z |
| format | Article |
| id | doaj.art-50b96054603d4a5e84be242253d364f6 |
| institution | Directory Open Access Journal |
| issn | 1201-9712 |
| language | English |
| last_indexed | 2024-12-21T01:39:28Z |
| publishDate | 2020-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | International Journal of Infectious Diseases |
| spelling | doaj.art-50b96054603d4a5e84be242253d364f62022-12-21T19:20:10ZengElsevierInternational Journal of Infectious Diseases1201-97122020-06-0195464467Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future…Guillaume Desoubeaux0Adrien Lemaignen1Stephan Ehrmann2CHRU de Tours, Parasitologie – Mycologie – Médecine tropicale, Tours, France; Université de Tours, INSERM U1100, Centre d’étude des pathologies respiratoires, Tours, France; Corresponding author at: Service de Parasitologie – Mycologie – Médecine tropicale, Pôle de Biologie médicale, Hôpital Bretonneau, 1er étage du Bâtiment B2A, 2 boulevard Tonnellé, 37044 CHU de Tours, France.CHRU de Tours, Médecine interne & Maladies infectieuses, Tours, FranceUniversité de Tours, INSERM U1100, Centre d’étude des pathologies respiratoires, Tours, France; CHRU de Tours, Médecine Intensive Réanimation, CIC INSERM 1415, CRICS-TriggerSep network, Tours, Francehttp://www.sciencedirect.com/science/article/pii/S120197122030148X |
| spellingShingle | Guillaume Desoubeaux Adrien Lemaignen Stephan Ehrmann Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future… International Journal of Infectious Diseases |
| title | Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future… |
| title_full | Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future… |
| title_fullStr | Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future… |
| title_full_unstemmed | Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future… |
| title_short | Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future… |
| title_sort | scientific rationale for inhaled caspofungin to treat pneumocystis pneumonia a therapeutic innovation likely relevant to investigate in a near future |
| url | http://www.sciencedirect.com/science/article/pii/S120197122030148X |
| work_keys_str_mv | AT guillaumedesoubeaux scientificrationaleforinhaledcaspofungintotreatpneumocystispneumoniaatherapeuticinnovationlikelyrelevanttoinvestigateinanearfuture AT adrienlemaignen scientificrationaleforinhaledcaspofungintotreatpneumocystispneumoniaatherapeuticinnovationlikelyrelevanttoinvestigateinanearfuture AT stephanehrmann scientificrationaleforinhaledcaspofungintotreatpneumocystispneumoniaatherapeuticinnovationlikelyrelevanttoinvestigateinanearfuture |